Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
The sedative drug thalidomide ([+]-alpha-phthalimidoglutarimide), once abandoned for causing birth defects in humans, has found new therapeutic license in leprosy and other diseases, with renewed teratological consequences. Although the mechanism of teratogenesis and determinants of risk remain unclear, related teratogenic xenobiotics are bioactivated by embryonic prostaglandin H synthase (PHS) to a free-radical intermediates that produce reactive oxygen species (ROS), which cause oxidative damage to DNA and other cellular macromolecules. Similarly, thalidomide is bioactivated by horseradish peroxidase, and oxidizes DNA and glutathione, indicating free radical-mediated oxidative stress. Furthermore, thalidomide teratogenicity in rabbits is reduced by the PHS inhibitor acetylsalicylic acid, indicating PHS-catalyzed bioactivation. Here, we show in rabbits that thalidomide initiates embryonic DNA oxidation and teratogenicity, both of which are abolished by pre-treatment with the free radical spin trapping agent alpha-phenyl-N-t-butylnitrone (PBN). In contrast, in mice, a species resistant to thalidomide teratogenicity, thalidomide does not enhance DNA oxidation, even at a dose 300% higher than that used in rabbits, providing insight into an embryonic determinant of species-dependent susceptibility. In addition to their therapeutic implications, these results constitute direct evidence that the teratogenicity of thalidomide may involve free radical-mediated oxidative damage to em…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They may cause direct cytotoxicity by inducing free radical mediated DNA damage.80”
From Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management (2024) · cites this paper as [80]
Citations
Cites
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.
Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844
A short history of thalidomide embryopathy
Lenz, W. (1988) · Teratology · doi:10.1002/tera.1420380303 · Cited by 784
Biochemical Toxicology of Chemical Teratogenesis
Wells, P. G., & Winn, L. M. (1996) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239609110574 · Cited by 160
Self-citationThalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
Gordon, G., Spielberg, S. P., Blake, D. A., & Balasubramanian, V. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2545 · Cited by 153
Schumacher, H., Smith, R. L., & Williams, R. T. (1965) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1965.tb02054.x · Cited by 144
Winn, L. M., & Wells, P. G. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00340-1 · Cited by 129
Self-citationProposed mechanisms of action in thalidomide embryopathy
Stephens, T. D. (1988) · Teratology · doi:10.1002/tera.1420380307 · Cited by 111
Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity1
Winn, L. M., & Wells, P. G. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00193-2 · Cited by 102
Self-citationFree Radical Intermediates of Phenytoin and Related Teratogens
Parman, T., Chen, G., & Wells, P. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25079 · Cited by 93
Self-citationCharacterization of a novel cytochrome P450 from the transformable cell line, C3H/10T1/2
Pottenger, L. H., & Jefcoate, C. R. E. (1990) · Carcinogenesis · doi:10.1093/carcin/11.2.321 · Cited by 88
Research works printed but not linked: 1
- Arlen, R.R. & Wells, P.G. Extracellular thiol-disulfide status reflecting chemical toxicity mediated via oxidative stress: Validation with paraquat and t-butylhydroperoxide and implications for phenytoin and thalidomide teratogenicity. FASEB J. 4, A608 (1990).
Cited by
Items 401–500 of 535
Nitrone chemistry: a versatile gateway to diverse heterocycles
Mohapatra, S., Prusty, K., Bhol, S., Panigrahi, G., & Nayak, S. (2026) · RSC Advances · doi:10.1039/d5ra07748f · Cited by 5
Species, Ethnic, and Individual Differences in Human Drug-Metabolizing Cytochrome P450 Enzymes
Yamazaki, H. (2014) · Springer eBooks · doi:10.1007/978-4-431-54992-5_17 · Cited by 5
Use of Thalidomide in Dermatological Indications
Kontogiannis, V., & Powell, R. J. (2000) · BioDrugs · doi:10.2165/00063030-200013040-00004 · Cited by 5
Durand, G. (2013) · Wiley eBooks · doi:10.1002/9781118355886.ch15 · Cited by 5
Targeted Therapies for Non-Hodgkin Lymphoma: Rationally Designed Combinations
Martin, P., & Leonard, J. P. (2007) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2007.s.022 · Cited by 5
Design and Synthesis of Thalidomide–Deoxyribonucleoside Chimeras
Suzuki, S., Yamamoto, T., Tokunaga, E., Nakamura, S., Tanaka, M., Sasaki, T., & Shibata, N. (2009) · Chemistry Letters · doi:10.1246/cl.2009.1046 · Cited by 5
Massive liver involvement in a patient with multiple myeloma during thalidomide treatment
Nozza, A., Castagna, L., Rahal, D., Magagnoli, M., & Santoro, A. (2003) · Cited by 5
Clinical trials: where are we now?
Knechtle, S. J. (2003) · Immunological Reviews · doi:10.1046/j.1600-065x.2003.00086.x · Cited by 5
Thalidomide alters c-MYB and PIM-1 signaling in K-562 cells☆
Thadani, N. N., McNamee, J. P., & Winn, L. M. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.02.010 · Cited by 5
Foran, J. M., & Sekeres, M. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50109-3 · Cited by 4
Adverse Outcome Pathways for Developmental Toxicity
Rogers, J. M. (2019) · Current topics in environmental health and preventive medicine · doi:10.1007/978-981-15-0520-1_17 · Cited by 4
Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells
Tang, X., Yocum, D. E., Dejonghe, D., & Nordensson, K. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01463.x · Cited by 4
Le thalidomide : vers de nouvelles indications ?
Combe, B. G. (2001) · Revue du Rhumatisme · doi:10.1016/s1169-8330(01)00208-3 · Cited by 4
Pharmacotherapy of multiple myeloma
Hussein, M. A. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.6.767 · Cited by 4
Selective Optimization of Side Activities: An Alternative and Promising Strategy for Lead Generation
Handler, N., Wolkerstorfer, A., & Buschmann, H. (2016) · Methods and principles in medicinal chemistry · doi:10.1002/9783527677047.ch09 · Cited by 3
Greene, M. E. (2008) · Ethics · doi:10.1086/589530 · Cited by 3
Tolerance Induction Through Mixed Chimerism
Wekerle, T., Blaha, P., Asari, R., Schmid, M. P., Kiss, C., Roth, E., & Mühlbacher, F. (2002) · European surgery. Supplement/European surgery · doi:10.1046/j.1563-2563.2002.02020.x · Cited by 3
Bhatia, S., & Wells, P. G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9182-2_22 · Cited by 3
Self-citationVargesson, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89773-0.00022-9 · Cited by 3
Rengel, B. D., Schüler‐Faccini, L., Fraga, L. R., Vianna, F. S. L., & Kowalski, T. W. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10790-w · Cited by 3
The Role of Biotransformation in Developmental Toxicity
Wells, P. G., & Winn, L. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02170-x · Cited by 3
Self-citationMechanizmy działania leków immunomodulujących w szpiczaku plazmocytowym
Piechnik, A., & Giannopoulos, K. (2011) · Via Medica Journals · Cited by 3
Gnanabakthan, N., & Hales, B. F. (2009) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20543 · Cited by 3
Nordquist, N., Luthman, H., Pettersson, U., & Eriksson, U. J. (2012) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.12.009 · Cited by 3
The Role of Drug Metabolism in Toxicity
Davis, C. D., & Hanumegowda, U. (2008) · Wiley eBooks · doi:10.1002/9780470439265.ch21 · Cited by 3
Thalidomide in the Management of Multiple Myeloma
Schey, S. (2002) · Hematology · doi:10.1080/1024533021000037199 · Cited by 3
More on the diabetic embryopathy
Eriksson, U. J., Simán, C. M., Groot, A. C. G., & Wisse, B. (2001) · Teratology · doi:10.1002/tera.1020 · Cited by 3
Recurrent Pregnancy Loss and Oxidative Stress
Aziz, N. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-041-0_7 · Cited by 3
Kurokawa, N., Kishimoto, T., Tanaka, K., Kondo, J., Takahashi, N., & Miura, Y. (2019) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2019.1637244 · Cited by 3
The Role of Biotransformation in Developmental Toxicity
Wells, P. G., & Winn, L. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01510-4 · Cited by 3
Self-citationBiochemical mechanisms of drug toxicity
Uetrecht, J., Grant, D. M., & Wells, P. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819869-8.00015-x · Cited by 3
Self-citationSekeres, M. A., & List, A. F. (2008) · Clinical Leukemia · doi:10.3816/clk.2008.n.003 · Cited by 3
Mühlbacher, J. R. (2003) · Online Publication Service of Würzburg University (Würzburg University) · Cited by 3
Schumann, P. G., Bundy, J. L., Haggard, D. E., Everett, L. J., Harrill, J., Harris, F. R., Ryoo, D., Collins, J., Rivetti, C., Campos, B., et al. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf127 · Cited by 2
High Anti-Inflammatory Activity and Low Toxicity of Thalidomide Analogs
Costa, V. S. C. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000282 · Cited by 2
Thalidomide – From a Banned Drug to Molecular Glues, PROTACs, and New Concepts in Drug Discovery
Yamamoto, J., Handa, H., & Yamaguchi, Y. (2024) · Wiley eBooks · doi:10.1002/9781394182862.ch24 · Cited by 2
Autism’s cancer connection: The anti-proliferation hypothesis and why it may matter
Ward, C. S. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.10.029 · Cited by 2
Thalidomide: an old wine in new bottle.
Mb, A. (2003) · PubMed · Cited by 2
Gera, A., Mohan, C., Madan, J., & Arora, S. (2019) · Current Organic Synthesis · doi:10.2174/1570179416666190306141318 · Cited by 2
Menzinger, S., & Laffitte, E. (2015) · EMC - Dermatología · doi:10.1016/s1761-2896(15)74836-3 · Cited by 2
Developmental and reproductive disorders
Rezk, B. M., & Sikka, S. C. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-382032-7.10069-4 · Cited by 2
Bioactivation II : Phase I (Non‐P450)
Hutzler, J. M., & Cerny, M. A. (2011) · Wiley eBooks · doi:10.1002/9780470921920.edm073 · Cited by 2
The Role of Drug Metabolism in Toxicity
Davis, C. D., & Hanumegowda, U. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse120 · Cited by 2
Tung, E. W. Y. (2012) · QSpace (Queen's University Library) · Cited by 2
Cereblon: molekularny cel leków immunomodulujących
Stępień, A., & Jamroziak, K. (2013) · Acta Haematologica Polonica · doi:10.1016/j.achaem.2013.08.001 · Cited by 1
Theoretical Study of Guanine Oxidation Catalyzed by a Ruthenium Complex with an Oxygen Molecule
Ikeda, K., & Shiota, Y. (2025) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.4c04862 · Cited by 1
Cereblon promotes influenza A virus replication through AMPK ubiquitination
Nguyen, T. H., Lee, D. J., Soliman, M., Sharif, M., Hosmillo, M. D. T., Kwon, H.-J., Jeong, S.-H., Cheong, D., Seo, H.-R., Lee, S., et al. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102815 · Cited by 1
Kinetics of oxidation of nitroxyl radicals by a coordinated superoxide
Mishra, R., Mukhopadhyay, S., & Banerjee, R. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.06.030 · Cited by 1
Development of In Vitro Method for Assaying Anti-Angiogenic Effect of Drugs
Akita, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803963-2.50002-8 · Cited by 1
Zaky, N. (2021) · Medico-Legal Update · doi:10.37506/mlu.v21i1.2384 · Cited by 1
History of IMiDs and Protein Degradation as a Pharmacological Modality
Yamamoto, J., Asatsuma‐Okumura, T., Ito, T., Yamaguchi, Y., & Handa, H. (2022) · Wiley eBooks · doi:10.1002/9781119774198.ch8 · Cited by 1
Repurposing Over-the-Counter Drugs and an Iron-Chelator as Antibacterial Agents
Gokarn, K., P, J. P. J., R, S. R. S., Pankar, P., & Odapalli, S. S. (2022) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3055 · Cited by 1
Talidomida y clase de las imidas inmunomoduladoras
Menzinger, S., & Laffitte, E. (2024) · EMC - Dermatología · doi:10.1016/s1761-2896(24)49756-2 · Cited by 1
Postimplantation diabetic embryopathy
Eriksson, U. J., & Wentzel, P. (2018) · CRC Press eBooks · doi:10.1201/9781315382104-41 · Cited by 1
Experimentelle Untersuchungen zur Pharmakokinetik lokal applizierten Thalidomids am Auge
Müller, M. (2005) · doi:10.18452/15191 · Cited by 1
Schey, S. (2003) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(03)00006-5 · Cited by 1
Nieden, N. I. Z. (2002) · DuEPublico (University of Duisburg-Essen) · Cited by 1
(2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200003000-00024 · Cited by 1
Toxicidad pulmonar por talidomida
Valero, F. C. (2003) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(03)75382-4 · Cited by 1
TNF Inhibitors in Dermatology: From Thalidomide to Biologics
Laffitte, E. (2010) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:6447
Pharmacogenetic studies in multiple myeloma
Corthals, S. L. (2011) · EUR Research Repository (Erasmus University Rotterdam)
Weiterentwicklung eines in vitro Embryotoxitätstests mit murinen embryonalen Stammzellen
Nieden, N. I. Z. (2002) · DuEPublico (University of Duisburg-Essen)
New Genetic Insights and Therapy in Multiple Myeloma
Wu, K. L. (2007) · EUR Research Repository (Erasmus University Rotterdam)
Bio-inspired Mechanism and Model Exploration of Software AgingPreprint
Chen, P., Qi, Y., Hou, D., & Liu, J. (2014) · arXiv (Cornell University) · doi:10.48550/arxiv.1409.1879
Maternofetal transport pathways during embryogenesis and organogenesis
Jauniaux, E. R. M., & Burton, G. J. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511933806.006
Machado, A. F. A., Scott, W. J., & Collins, M. D. (2003) · Springer eBooks · doi:10.1007/0-306-48412-9_20
Dissecting the genotype to phenotype relationships of genomic disorders
Hart, L. (2013) · Sussex Research Online (University of Sussex)
The place of thalidomide in the treatment of multiple myeloma
Corso, A., & Mangiacavalli, S. (2008) · Oncology Reviews · doi:10.4081/157
Wendling, D., Toussirot, É., & Michel, F. (2000) · Revue du Rhumatisme · doi:10.1016/s1169-8330(00)80001-0
In‐Depth Look: Anti‐TNF‐α Therapies
Chatterjee, S., & Gaddameedhi, S. (2011) · Wiley eBooks · doi:10.1002/9780470571224.pse463
サリドマイドの胚・胎児発生毒性研究におけるKbl:JWウサギの有用性
Kawamura, Y. (2014) · Institutional Repositories DataBase (IRDB)
EFECTO DE LA SPIRULINA MAXIMA CONTRA LA TERATOGENICIDAD Y GENOTOXICIDAD PRODUCIDAS POR HIDROXIUREA
Sanchez, J. V. (2012) · REMERI - Red Mexicana de Repositorios Institucionales
Einfluß von Thalidomid auf die Atherogenese im Tiermodell der ApoE-/-/LDL-/--Doppel- Knockout Maus
Gunkel, I. A., & Justus Liebig University Giessen (2012) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-13773
Effects of Thalidomide on Bone Sialoprotein Gene Transcription
Kim, K. M., Wang, Z., Kato, A., & Ogata, Y. (2015) · International Journal of Oral-Medical Sciences · doi:10.5466/ijoms.13.35
Mechanisms of Thalidomide Teratogenicity
Ito, T., Ando, H., & Handa, H. (2011) · KAGAKU TO SEIBUTSU · doi:10.1271/kagakutoseibutsu.49.819
The use of thalidomide in contemporary medical practice: revival of a medical pariah
Schwartzbauer, H. R., & Tami, T. A. (2001) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/00020840-200106000-00011
Principles of Systemic Cancer Therapy
Thirlwell, C., Bridgewater, J. A., & Cave, J. (2010) · CRC Press eBooks · doi:10.3109/9781841847498-29
Tan, K. P. (2009) · TSpace (University of Toronto)
Role of Xenobiotic Metabolism in Developmental and Reproductive Toxicity
Kulkarni, A. P. (2005) · Informa Healthcare eBooks · doi:10.1201/9781420040548.ch12
Ramkissoon, A. (2012) · TSpace (University of Toronto)
Thalidomide-induced teratogenesis in gray short-tailed opossums (Monodelphis domestica)
Sorensen, D. W. (2015) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Lamparter, C. L. (2016) · QSpace (Queen's University Library)
Oxygen bubbles to predict sensitivity to IMiDs
Raab, M. S. (2017) · Blood · doi:10.1182/blood-2017-01-760512
The Effects of ROS and DNA Repair on Methylmercury-initiated Neurodevelopmental Deficits
Lam, K. C. H. (2014) · TSpace (University of Toronto)
Costa, V. S. C. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Biochemical Determinants of Methanol Developmental Toxicity in Rabbits
Sweeting, J. N. (2013) · TSpace (University of Toronto)
Jóhannesson, Þ. (2003) · Hirsla (Landspítali University Hospital)
Gomes, J. D. A. (2017) · Americanae (AECID Library)
Zangari, M., Anaissie, E. J., Epstein, J., Shaughnessy, J. D., Ayers, D., Barlogie, B., Desikan, R. K., Eddlemon, P., Spencer, H. J., Zeldis, J. B., et al. (2013)
Gu, Y. (2012) · NDSU Repository (North Dakota State University)
Priami, C. (2018) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/priami-chiara_phd2018-02-26
Prenatal Arsenic Exposure and Birth Outcomes in a Longitudinal Birth Cohort in Bangladesh
Rahman, M. M. (2017) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Ronnebaum, J. M. (2019) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3152
Investigating the Mechanism and Species-Specificity of Thalidomide Derivatives
Fink, E. C. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Roles of Kupffer Cells in Alcoholic Liver Disease
Takei, Y., Enomoto, N., Ikejima, K., Yamashina, S., Kitamura, T., & Sato, N. (2005) · Elsevier eBooks · doi:10.1016/b978-012564370-2/50060-x
New Activities of CELMoDs, Cereblon E3 Ligase-modulating Drugs
Matyskiela, M. E., Clayton, T., Thompson, J. W., Carroll, C. W., Bateman, L. A., LeBrun, L. A., & Chamberlain, P. P. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160691-00094
Isaza-Correa, J. M. (2018) · Maynooth University ePrints and eTheses Archive (Maynooth University)
Metadata
- Authors
- Parman, T., Wiley, M. J., & Wells, P. G.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Wells, Peter G.
- ORCID
- Wells, Peter G.
- Venue
- Nature Medicine
- Published
- 1999-05
- Volume
- 5
- Issue
- 5
- Pages
- 582-585
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- DOI
- 10.1038/8466
- OpenAlex
- W1568733499
- Semantic Scholar
- 584f5e94f837063f4ceb1b3ddec9c4c9c9ed44ff
- Cited by
- 495
- References
- 25
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 11 · 2023: 2 · 2022: 10 · 2021: 12 · 2020: 10 · 2019: 14 · 2018: 14 · 2017: 10 · 2016: 18 · 2015: 19 · 2014: 13 · 2013: 19 · 2012: 19
- FWCI
- 32.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- thalidomide, teratogenicity, oxidative DNA damage, free radicals, reactive oxygen species, prostaglandin H synthase, horseradish peroxidase, glutathione oxidation, spin trapping, aspirin, embryonic development, congenital malformations
- MeSH terms
- Animals, Cyclic N-Oxides, DNA Damage, Drug Resistance, Embryo, Mammalian, Female, Free Radicals, Hernia, Umbilical, Hypnotics and Sedatives, Nitrogen Oxides, Oxidation-Reduction, Pregnancy, Rabbits, Species Specificity, Teratogens, Thalidomide, Free Radical Scavengers, Limb Deformities, Congenital, Embryo Loss, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.